I-Atazanavir Sulfate CAS 229975-97-7 Purity ≥99.0% API Factory Anti-HIV HIV-1 Protease Inhibitor
Nikeza Ngokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
Igama Lekhemikhali: Atazanavir Sulfate
I-CAS: 229975-97-7
I-HIV-1 Protease Inhibitor
Ikhwalithi ephezulu ye-API, Ukukhiqiza Kwezentengiso
Igama Lekhemikhali | I-Atazanavir sulfate |
Omqondofana | I-BMS-232632 Sulfate |
Inombolo ye-CAS | 229975-97-7 |
Inombolo yeCAT | I-RF-API71 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu |
I-Molecular Formula | I-C38H52N6O7.H2SO4 |
Isisindo samangqamuzana | 802.93 |
I-Melting Point | 195.0 ~ 198.0℃ |
Ukuncibilika | Ayincibiliki Emanzini, Ayincibiliki ku-DMSO |
Isitoreji Sesikhathi Eside | Gcina Isikhathi Eside ku -20 ℃ |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe noma Engamhlophe |
I-sulfate | 12.0~12.5% |
Ukulahlekelwa Ekumisweni | ≤0.50% |
Izinsalela ekushiseni | ≤0.10% |
Izinsimbi Ezisindayo | ≤20ppm |
Ukungcola Okukodwa | ≤0.30% |
Ukungcola Okuphelele | ≤1.0% |
Ukuhlanzeka/Ukuhlaziya Indlela | ≥99.0% (HPLC) |
pH | 5.0~8.0 |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-HIV-1 Protease Inhibitor Anti-HIV |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, I-Cardboard Drum, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Atazanavir Sulfate (BMS-232632 Sulfate) (CAS: 229975-97-7) iwusawoti we-sulfate we-atazanavir ekhetha kakhulu i-HIV-1 protease inhibitor, iyi-protease inhibitor yokuqala egunyazwe ukusetshenziswa kanye ngosuku.I-Atazanavir Sulfate iyi-substrate kanye ne-inhibitor ye-CYP3A4, kanye ne-inhibitor kanye ne-inducer ye-P-glycoprotein (P-gp).I-Atazanavir Sulfate iphinde ibe yi-SARS-CoV 3CLpro inhibitor ene-IC50 ye-3.49 μM.I-Atazanavir Sulfate iyi-azapeptide kanye ne-HIV-protease inhibitor esetshenziswa ekwelapheni ukutheleleka nge-HIV kanye nengculazi ngokuhlangana namanye ama-Anti-HIV Agents, yakhiwe futhi yethulwa ngabakwaBristol-Myers Squibb (BMS), ngaphansi kwelayisensi yomhlaba wonke evela kwaNovartis, ekwelapheni ukutheleleka nge-HIV.I-Atazanavir yethulwa e-US njenge-Reyataz™ ngoJulayi 2003. I-Antiviral.I-Atazanavir ikhombise ukuthi inamandla kakhulu kunezinhlanu ezigunyazwe njengamanje i-HIV-1 protease inhibitors.I-Atazanavir ivimbela ngokukhethekile ukucutshungulwa kwegciwane okuqondene ngqo negciwane le-Gag ne-Gag-Pol polyprotein kumaseli ane-HIV-1 ngokubophezela endaweni esebenzayo ye-HIV-1 protease, ngaleyo ndlela ivimbele ukwakheka kwama-virion asebekhulile.I-Atazanavir ayisebenzi ngokumelene ne-HIV-2.